Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04429568 · ClinicalTrials.gov registry record · NA
THC Crossover Study
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04429568 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants.
The verdict
NCT04429568, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.
Interventions
- OTHER Smoked Cannabis
- OTHER Vaped Cannabis
- OTHER Tobacco Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2024-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04429568
The ClinicalTrials.gov registry entry for NCT04429568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Smoked Cannabis is the first listed.
NCT04429568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04429568 about?
NCT04429568 is a clinical study titled "THC Crossover Study". This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the dif...
What is the current status of trial NCT04429568?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-10-30. Estimated completion is 2024-06-25.
What interventions are being tested in trial NCT04429568?
The interventions under investigation include: Smoked Cannabis (OTHER), Vaped Cannabis (OTHER), Tobacco Cigarette (OTHER).
Who is sponsoring clinical trial NCT04429568?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.